Health ❯ Healthcare

Drug Development

Clinical Trials Clinical Research Regulatory Affairs FDA Approval Regulatory Approval Therapeutics FDA Regulations Pharmaceutical Research Efficacy Studies Oncology

Edgewise Reports Favorable Interim Safety in Phase 2 HCM Trial of EDG-7500

The readout underscores a clean cardiac safety profile, preserving the timeline for full Part D data in Q2 2026.

Robotic Click Chemistry Yields Iridium Antibiotic Lead in Days

AstraZeneca’s LATIFY Phase 3 Finds No Survival Benefit for Ceralasertib Plus Imfinzi in Pre-Treated NSCLC

BioMarin to Acquire Amicus for $4.8 Billion in Cash

Novo Nordisk Files FDA Application for Weekly CagriSema Obesity Shot as GLP-1 Competition Intensifies

Athira Pharma Secures Exclusive Lasofoxifene Rights, Raises $90 Million to Advance Phase 3 Breast Cancer Program

FDA Approves Rybrevant Faspro, a 5‑Minute Subcutaneous Amivantamab for EGFR‑Mutated Lung Cancer

Pfizer Sets 2026 Targets Below Wall Street as COVID Sales Fade, Patent Pressure Builds

DBV Peanut Allergy Patch Succeeds in Pivotal Phase 3, Setting Up 2026 FDA Filing

Nektar’s Alopecia Drug Misses Phase 2b Goal as Company Cites Ineligible Patients, Plans Phase 3

FDA Grants National Priority Voucher to J&J’s Tecvayli–Darzalex Combo in Multiple Myeloma

Study Finds CBD–THC Combination Kills Ovarian Cancer Cells in Lab

Study Finds FDA Pivotal Trials Rarely Reflect U.S. Diversity as Black and Hispanic Enrollment Falls

Lilly’s Imlunestrant Data Show Stronger Results With Abemaciclib, Delayed Chemotherapy in ER+ Breast Cancer

Tucatinib Added to First-Line HER2 Maintenance Prolongs Progression-Free Survival in Phase 3 Trial

Teclistamab–Daratumumab Delivers Major Survival Gains in Relapsed Myeloma, Phase 3 Data Show

Terns’ TERN-701 Shows Strong CML Responses in CARDINAL, Setting 320 mg and 500 mg Phase 2 Doses

Wave Life Sciences Soars on Obesity Trial Signal as It Begins $250 Million Stock Offering

FDA Grants Breakthrough Therapy Designation to Incyte’s CALR‑Targeting Antibody as ASH Data Show Early Efficacy in Myelofibrosis

Scientists Film Flu Viruses Entering Human Cells in Real Time